Amylyx Pharmaceuticals, Inc.
Industry: Life Sciences ・ $AMLX on Nasdaq
Insider Sale
+$95,384
-0.21%
Shares
Shares Volume: 5,841 Shares
Average Share Price: $16.33
INSIDER
Klee Justin B.
Co-Chief Executive Officer (Director)
reported on Jan 11 2024
traded on Jan 9 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 2,836,776 |
| PURCHASES/SALES 1Y | 0 / 2 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,655,691.76 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 2 / 22 |
| P/S VALUE RATIO | 0.003 |
| AVERAGE SALE VALUE | $1,647,911.74 |
| COMPANY PREVIOUS TRADES |